Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Posted Basic Consolidated EPS Of $-0.534

0

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) annual basic consolidated EPS was $-0.534 for the period ended 2015-12-31. The basic consolidated EPS was $-0.534 for the quarter ended 2015-12-31.

EPS from continuing operations

Synta Pharmaceuticals Corp. (NASDAQ:SNTA)’s basic EPS from continuing operations was $-0.534 for the fiscal year 2015-12-31. For the quarter ended 2015-12-31 it stood at $-0.534

EPS contribution from parent

From the parent company Synta Pharmaceuticals Corp. (NASDAQ:SNTA) posted basic EPS of $-0.534 for the fiscal ended 2015-12-31. For the quarter that ended on 2015-12-31 the figure stood at $-0.534.

Basic net EPS

The Basic net EPS of Synta Pharmaceuticals Corp. (NASDAQ:SNTA) was $-0.53 for the period ended 2015-12-31. The figure stood at $-0.53 for the quarter that ended 2015-12-31.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2015-12-31 stood at $-0.534. While the figure for the quarter ended 2015-12-31 stood at $-0.534.

Basic diluted EPS

The diluted EPS from continuing operation of Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stood at $-0.534 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-0.534

Net diluted EPS

The Net diluted EPS was $-0.53 for the fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 stood at $-0.53.

Diluted EPS from parent

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) diluted EPS from the parent company for the fiscal 2015-12-31 was $-0.534. The figure for the quarter ended 2015-12-31 was $-0.534

The net basic EPS was $-0.87 for fiscal 2015-12-31. The figure for the quarter ended 2015-12-31 was $-0.87.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 2 times, 1 visits today)